Cargando…
NFκB signaling in alveolar rhabdomyosarcoma
Alveolar rhabdomyosarcoma (aRMS) is a pediatric soft tissue cancer commonly associated with a chromosomal translocation that leads to the expression of a Pax3:Foxo1 or Pax7:Foxo1 fusion protein, the developmental underpinnings of which may give clues to its therapeutic approaches. In aRMS, the NFκB–...
Autores principales: | Cleary, Megan M., Mansoor, Atiya, Settelmeyer, Teagan, Ijiri, Yuichi, Ladner, Katherine J., Svalina, Matthew N., Rubin, Brian P., Guttridge, Denis C., Keller, Charles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5611971/ https://www.ncbi.nlm.nih.gov/pubmed/28883017 http://dx.doi.org/10.1242/dmm.030882 |
Ejemplares similares
-
Preclinical testing of the glycogen synthase kinase-3β inhibitor tideglusib for rhabdomyosarcoma
por: Bharathy, Narendra, et al.
Publicado: (2017) -
Defining the Extracellular Matrix of Rhabdomyosarcoma
por: Lian, Xiaolei, et al.
Publicado: (2021) -
Rb1 loss modifies but does not initiate alveolar rhabdomyosarcoma
por: Kikuchi, Ken, et al.
Publicado: (2013) -
Classical NF-κB Metabolically Reprograms Sarcoma Cells Through Regulation of Hexokinase 2
por: Londhe, Priya, et al.
Publicado: (2018) -
Preclinical rationale for entinostat in embryonal rhabdomyosarcoma
por: Bharathy, Narendra, et al.
Publicado: (2019)